BACKGROUND: Restless legs syndrome (RLS) is a common sensorimotor disorder whose incidence is not known. The aim of the study was to determine the incidence and correlates of RLS in a population-based sample. METHODS: We obtained data from the Tucson Cohort of the Sleep Heart Health Study, a prospective multicenter study. This cohort included 535 participants aged ≥ 40 years, who answered questions regarding RLS on the 2002 and 2006 sleep surveys. For this study, RLS was defined as the presence of all 4 International RLS Study Group criteria, with symptoms occurring ≥ 5 days/month and associated with at least moderate distress. RESULTS: Mean age of the predominantly Caucasian (90.8%) participants on the 2002 survey was 59.8 ± 9.7 years; 52.2% were women. RLS prevalence was 4.1% in 2002 and 7.7% in 2006. The yearly incidence of RLS was 1.7% (6.6% over 4 years). Multivariate analyses demonstrated that estrogen use (OR = 2.5, 95% CI: 1.17-5.10) and self-reported obstructive lung disease (OR = 2.8, 95% CI: 1.37-5.83) were independent risk factors predicting incident RLS. Incident RLS was associated with higher prevalence of insomnia (26.5% vs. 7.6%, p = 0.001), increased sleepiness (38.2% vs. 22%, p = 0.036); and higher sleeping pill use in 2006 (23.5% vs. 9.7%, p = 0.019). CONCLUSION: The incidence of RLS in this population sample was 1.7% per year. Use of estrogen and history of obstructive lung disease were associated with a significantly higher incidence of RLS. RLS, in turn, was associated with insomnia and increased sleepiness.
BACKGROUND:Restless legs syndrome (RLS) is a common sensorimotor disorder whose incidence is not known. The aim of the study was to determine the incidence and correlates of RLS in a population-based sample. METHODS: We obtained data from the Tucson Cohort of the Sleep Heart Health Study, a prospective multicenter study. This cohort included 535 participants aged ≥ 40 years, who answered questions regarding RLS on the 2002 and 2006 sleep surveys. For this study, RLS was defined as the presence of all 4 International RLS Study Group criteria, with symptoms occurring ≥ 5 days/month and associated with at least moderate distress. RESULTS: Mean age of the predominantly Caucasian (90.8%) participants on the 2002 survey was 59.8 ± 9.7 years; 52.2% were women. RLS prevalence was 4.1% in 2002 and 7.7% in 2006. The yearly incidence of RLS was 1.7% (6.6% over 4 years). Multivariate analyses demonstrated that estrogen use (OR = 2.5, 95% CI: 1.17-5.10) and self-reported obstructive lung disease (OR = 2.8, 95% CI: 1.37-5.83) were independent risk factors predicting incident RLS. Incident RLS was associated with higher prevalence of insomnia (26.5% vs. 7.6%, p = 0.001), increased sleepiness (38.2% vs. 22%, p = 0.036); and higher sleeping pill use in 2006 (23.5% vs. 9.7%, p = 0.019). CONCLUSION: The incidence of RLS in this population sample was 1.7% per year. Use of estrogen and history of obstructive lung disease were associated with a significantly higher incidence of RLS. RLS, in turn, was associated with insomnia and increased sleepiness.
Entities:
Keywords:
COPD; Restless Legs Syndrome; estrogen; incidence; obstructive airway disease
Authors: Wayne Hening; Arthur S Walters; Richard P Allen; Jacques Montplaisir; Andrew Myers; Luigi Ferini-Strambi Journal: Sleep Med Date: 2004-05 Impact factor: 3.492
Authors: J Winkelmann; T C Wetter; V Collado-Seidel; T Gasser; M Dichgans; A Yassouridis; C Trenkwalder Journal: Sleep Date: 2000-08-01 Impact factor: 5.849
Authors: Richard P Allen; Daniel Picchietti; Wayne A Hening; Claudia Trenkwalder; Arthur S Walters; Jacques Montplaisi Journal: Sleep Med Date: 2003-03 Impact factor: 3.492
Authors: C Trenkwalder; H-P Hundemer; A Lledo; J Swieca; O Polo; T C Wetter; L Ferini-Strambi; H de Groen; D Quail; U Brandenburg Journal: Neurology Date: 2004-04-27 Impact factor: 9.910
Authors: Johan Verbraecken; Elske Hoitsma; Chris P M van der Grinten; Nicolle A M Cobben; Emiel F M Wouters; Marjolein Drent Journal: Sarcoidosis Vasc Diffuse Lung Dis Date: 2004-06 Impact factor: 0.670
Authors: Deborah A Nichols; Richard P Allen; John H Grauke; John B Brown; Matthew L Rice; Pamela R Hyde; William C Dement; Clete A Kushida Journal: Arch Intern Med Date: 2003-10-27
Authors: Timothy I Morgenthaler; Janet B Croft; Leslie C Dort; Lauren D Loeding; Janet M Mullington; Sherene M Thomas Journal: J Clin Sleep Med Date: 2015-09-15 Impact factor: 4.062
Authors: Susan E Mackie; R Kathryn McHugh; Katherine McDermott; Margaret L Griffin; John W Winkelman; Roger D Weiss Journal: J Subst Abuse Treat Date: 2016-10-06
Authors: Mark I Boulos; Brian J Murray; Ryan T Muir; Fuqiang Gao; Gregory M Szilagyi; Menal Huroy; Alexander Kiss; Arthur S Walters; Sandra E Black; Andrew S Lim; Richard H Swartz Journal: Sleep Date: 2017-03-01 Impact factor: 5.849